Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LIVE, ANVS and HYRE By: The Klein Law Firm via AccessWire September 30, 2021 at 13:00 PM EDT NEW YORK, NY / ACCESSWIRE / September 30, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.Live Ventures Incorporated (NASDAQ:LIVE)Class Period: December 28, 2016 - August 3, 2021Lead Plaintiff Deadline: October 12, 2021According to the complaint, Live Ventures Incorporated allegedly made materially false and/or misleading statements and/or failed to disclose that: 1) Live's earnings per share for FY 2016 was actually only $6.33 per share; (2) the Company used an artificially low share count to boost the earnings per share by 40%; (3) Live had overstated pretax income for fiscal 2016 by 20% by including $915,500 of "other income" related to certain amendments that were not negotiated until after the close of the fiscal year; (4) Live's acquisition of ApplianceSmart did not close during first quarter 2017; (5) using December 30, 2017 as the "acquisition date" and recognizing income therefrom did not conform to generally accepted accounting principles; (6) by falsely stating that the acquisition closed during the quarter, Live recognized bargain purchase gain, which enabled the Company to report positive net income in what would otherwise have been an unprofitable quarter; (7) between fiscal 2016 and fiscal 2018, Live's CEO received approximately 94% more in compensation than was disclosed to investors; and (8) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Learn about your recoverable losses in LIVE: https://www.kleinstocklaw.com/pslra-1/live-ventures-incorporated-loss-submission-form?id=20007&from=1Annovis Bio, Inc. (NYSE American:ANVS)Class Period: May 21, 2021 - July 28, 2021Lead Plaintiff Deadline: October 18, 2021The ANVS lawsuit alleges that Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Learn about your recoverable losses in ANVS: https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=20007&from=1HyreCar Inc. (NASDAQ:HYRE)Class Period: May 14, 2021 - August 10, 2021Lead Plaintiff Deadline: October 26, 2021The HYRE lawsuit alleges HyreCar Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) HyreCar had materially understated its insurance reserves; (b) HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period; (c) HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods; (d) HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result; (e) HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and (f) as a result, HyreCar's operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar's purported gross margin, EBITDA (earnings before interest, taxes, depreciation, and amortization), and net loss trajectories.Learn about your recoverable losses in HYRE: https://www.kleinstocklaw.com/pslra-1/hyrecar-inc-loss-submission-form?id=20007&from=1Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118jk@kleinstocklaw.comTelephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.comSOURCE: The Klein Law FirmView source version on accesswire.com: https://www.accesswire.com/666300/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-LIVE-ANVS-and-HYRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LIVE, ANVS and HYRE By: The Klein Law Firm via AccessWire September 30, 2021 at 13:00 PM EDT NEW YORK, NY / ACCESSWIRE / September 30, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.Live Ventures Incorporated (NASDAQ:LIVE)Class Period: December 28, 2016 - August 3, 2021Lead Plaintiff Deadline: October 12, 2021According to the complaint, Live Ventures Incorporated allegedly made materially false and/or misleading statements and/or failed to disclose that: 1) Live's earnings per share for FY 2016 was actually only $6.33 per share; (2) the Company used an artificially low share count to boost the earnings per share by 40%; (3) Live had overstated pretax income for fiscal 2016 by 20% by including $915,500 of "other income" related to certain amendments that were not negotiated until after the close of the fiscal year; (4) Live's acquisition of ApplianceSmart did not close during first quarter 2017; (5) using December 30, 2017 as the "acquisition date" and recognizing income therefrom did not conform to generally accepted accounting principles; (6) by falsely stating that the acquisition closed during the quarter, Live recognized bargain purchase gain, which enabled the Company to report positive net income in what would otherwise have been an unprofitable quarter; (7) between fiscal 2016 and fiscal 2018, Live's CEO received approximately 94% more in compensation than was disclosed to investors; and (8) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Learn about your recoverable losses in LIVE: https://www.kleinstocklaw.com/pslra-1/live-ventures-incorporated-loss-submission-form?id=20007&from=1Annovis Bio, Inc. (NYSE American:ANVS)Class Period: May 21, 2021 - July 28, 2021Lead Plaintiff Deadline: October 18, 2021The ANVS lawsuit alleges that Annovis Bio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.Learn about your recoverable losses in ANVS: https://www.kleinstocklaw.com/pslra-1/annovis-bio-inc-loss-submission-form?id=20007&from=1HyreCar Inc. (NASDAQ:HYRE)Class Period: May 14, 2021 - August 10, 2021Lead Plaintiff Deadline: October 26, 2021The HYRE lawsuit alleges HyreCar Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) HyreCar had materially understated its insurance reserves; (b) HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period; (c) HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods; (d) HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result; (e) HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and (f) as a result, HyreCar's operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar's purported gross margin, EBITDA (earnings before interest, taxes, depreciation, and amortization), and net loss trajectories.Learn about your recoverable losses in HYRE: https://www.kleinstocklaw.com/pslra-1/hyrecar-inc-loss-submission-form?id=20007&from=1Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118jk@kleinstocklaw.comTelephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.comSOURCE: The Klein Law FirmView source version on accesswire.com: https://www.accesswire.com/666300/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-LIVE-ANVS-and-HYRE